The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-051: An update on the phase 2 results of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1–positive advanced, relapsed or refractory solid tumor or lymphoma.
 
Birgit Geoerger
No Relationships to Disclose
 
Hyoung Jin Kang
No Relationships to Disclose
 
Michal Yalon-Oren
No Relationships to Disclose
 
Lynley V. Marshall
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - Bayer; Celgene
 
Catherine Vezina
Honoraria - St. Alexius Medical Center
 
Alberto S. Pappo
No Relationships to Disclose
 
Theodore Willis Laetsch
Consulting or Advisory Role - Lilly; Loxo; Novartis
Research Funding - Pfizer (Inst)
 
Antonio Sergio Petrilli
No Relationships to Disclose
 
Martin Ebinger
No Relationships to Disclose
 
Jacek Toporski
No Relationships to Disclose
 
Julia Glade-Bender
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Ignyta (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; Novartis
 
Wayne Nicholls
No Relationships to Disclose
 
Elizabeth Fox
Research Funding - Ignyta (Inst)
Travel, Accommodations, Expenses - Helsinn Therapeutics
Other Relationship - Helsinn Therapeutics
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo; Roche/Genentech
 
Margaret Macy
Stock and Other Ownership Interests - Johnson & Johnson; Varian Medical Systems
Consulting or Advisory Role - Ventana Medical Systems
 
Susan Lerner Cohn
Stock and Other Ownership Interests - Abbvie; Amgen; Amgen (I); Jazz Pharmaceuticals; Lilly; Merck; Merck (I); Pfizer; Pfizer (I); Resmed (I); Sanofi; Stryker; Stryker (I); United Therapeutics; United Therapeutics (I); Varex Imaging; Varian Medical Systems (I); Vermillion; Vermillion
Research Funding - Merck (Inst); United Therapeutics (Inst)
 
Kumudu Pathiraja
Employment - Merck
 
Scott J. Diede
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Scot Ebbinghaus
Employment - Merck
Leadership - Merck
Stock and Other Ownership Interests - Merck
 
Navin R. Pinto
No Relationships to Disclose